Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is effective for hair loss but has controversial side effects.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Oral contraceptives can cause nausea, headaches, mood changes, and other side effects, especially early on.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.